Skip to main content
E

Exo

Exo develops handheld ultrasound devices integrated with artificial intelligence for imaging and therapeutic applications in medical settings. These devices enhance diagnostic accuracy and treatment efficiency, addressing the need for portable and user-friendly imaging solutions in healthcare.

Santa Clara, CubaFounded 201519810K+ followers
Updated 3 months ago

Funding

$349.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional ultrasound systems are often bulky, expensive, and require specialized training, limiting their accessibility and utility in various clinical settings. This can lead to delays in diagnosis and treatment, particularly in emergency situations or resource-constrained environments.

Solution

Exo develops handheld ultrasound devices that leverage artificial intelligence to enhance imaging capabilities and therapeutic applications. These portable devices aim to provide clinicians with rapid, high-quality imaging at the point of care, improving diagnostic accuracy and treatment efficiency. The integration of AI algorithms facilitates image interpretation and guidance, potentially reducing the need for extensive training and expanding the use of ultrasound technology across different medical specialties.

Target Audience

The primary target audience includes physicians, nurses, and other healthcare professionals in emergency medicine, critical care, primary care, and other specialties where rapid and accurate imaging is crucial.

Features

  • Handheld ultrasound probe for portable imaging
  • Integrated AI algorithms for image enhancement and interpretation
  • Wireless connectivity for seamless data transfer and integration with electronic health records
  • User-friendly interface designed for ease of use and rapid image acquisition
  • Therapeutic applications, including targeted drug delivery and tissue ablation
  • Advanced imaging modes, such as Doppler and elastography
  • Cloud-based platform for remote collaboration and data analysis
This profile is AI-generated and may contain inaccuracies.